Back to Results
First PageMeta Content
Medical research / Food and Drug Administration / Clinical pharmacology / Pharmaceutical industry / Expanded access / Clinical research / Investigational New Drug


CMX001 is a Potential Treatment for Adenovirus Infection: Preliminary Antiviral Activity Results from an Open-label, Expanded Access Study of CMX001 for the Treatment of Serious or Life-threatening Diseases Caused by Do
Add to Reading List

Document Date: 2016-05-24 12:17:21


Open Document

File Size: 537,83 KB

Share Result on Facebook